Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies	Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Not yet recruiting	Phase 3	2026-06-09		NCT07635511

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The First Affiliated Hospital of Soochow University	164

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials